Study: Cost of developing a new drug tops $1.1 billion

Share this article:

Much has been written about the high cost of drugs. Less has been publicized about how much it costs to get medications to market. Such costs topped $1.1 billion in the 2011-2012 season, according to a new study by Deloitte and Thomson Reuters. That's up $100 million from 2010-2011, based on an examination of a dozen leading firms.

Among the study's findings: The industry has seen a jump in approvals, with 41 between 2011 and 2012, up from 32 between 2010 and 2011. Researchers said the 41 approvals in the 2011-2012 season amounted to $211 billion in projected sales, down from the $309 billion in forecasted sales of the 32 items approved the year before. So while more drugs are getting to market, they are generating smaller returns.

Share this article:

More in Products

Aviv REIT offers public stock

Aviv REIT announced the public offering of 8 million shares of common stock at a public offering price of $24.10 per share.

NCAL unveils 2014 Assisted Living Week logo

NCAL unveils 2014 Assisted Living Week logo

The National Center for Assisted Living is encouraging communities to use the 2014 "The Magic of Music" logo to celebrate National Assisted Living Week.

New healthcare educational catalog available

New healthcare educational catalog available

Nasco has released its 2014-2015 Health Care Educational Materials catalog, which focuses on training with versatile medical procedure simulators.